TrialNature medicine2022

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.

Andrea Sartore-Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.